Epigenomics AG

Type: Company

Name: Epigenomics AG

First reported May 10 2013 - Updated May 10 2013 - 1 reports

Salk Researchers Chart Epigenomics of Stem Cells That Mimic Early Human Development

LA JOLLA, CA – Scientists have long known that control mechanisms known collectively as "epigenetics" play a critical role in human development, but they did not know precisely how alterations in this extra layer of biochemical instructions in DNA contribute ... [Published ScienceNewsline - May 10 2013]

Entities: Epigenomics AG, Salk, Stem Cell

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Epigenomics AG Announces Q1 2013 Financial Results and Reports on Operational Highlights

- Epigenomics AG (Frankfurt Prime Standard: ECX), the German-American cancer molecular diagnostics company, today announced its financial results for the first quarter ending March 31, 2013.? U.S. Food and Drug Administration (FDA) accepted Premarket ... [Published BioSpace - May 08 2013]

Entities: Epigenomics AG, United States, Colorectal Cancer

First reported May 08 2013 - Updated May 08 2013 - 2 reports

PRESS RELEASE: Epigenomics AG: Epigenomics AG Announces Q1 2013 Financial Results and Reports on Operational Highlights

(MORE TO FOLLOW) Dow Jones NewswiresMay 08, 2013 02:30 ET (06:3 ... [Published Tradesignal Online - May 08 2013]

Entities: Epigenomics AG

First reported Apr 28 2013 - Updated Apr 28 2013 - 1 reports

University of Texas M D Anderson Cancer Center

DCI DEEP Mini Symposium

Keynote: Sharon Dent, MD, PhD (University of Texas MD Anderson Cancer Center)Sponsors:Duke Center for Human Genetics and Duke Cancer InstituteLocation:Mary Duke Biddle Trent Semans Center for Health Education - MapWhen:Contact:Broz, SarahEmail:Phone: ... [Published Duke University - Apr 28 2013]

Entities: Mary Duke Biddle, Epigenomics AG, Epigenetics, University of Texas M D Anderson Cancer Center

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

EMBO Conference Series: Chromatin and Epigenetics

TopicsChromatin regulation and dynamicsSignalling to chromatinNuclear architecture and dynamicsDevelopmental epigeneticsEpigenomicsEpigenetics and human diseaseGenome stabilityEnvironmental epigenetics and transgenerational inheritanceFunctional geno ... [Published Bionity.com - Apr 23 2013]

Entities: Chromatin, Epigenetics, Epigenomics AG, Genome, Biology

First reported Apr 19 2013 - Updated Apr 20 2013 - 2 reports

EXACT Sciences Corp

Colonoscopy alternative, but not yet a replacement

A new noninvasive screening test can detect most cases of colorectal cancer and also many precancerous polyps, potentially helping to sharply reduce the death toll from the disease, according to results of a study released Thursday.Still, the results ... [Published Bend Bulletin - Apr 19 2013]

Entities: colonoscopy, EXACT Sciences Corp, precancerous polyps, Colorectal Cancer

First reported Apr 19 2013 - Updated Apr 19 2013 - 1 reports

National institutes of Health

April 2013 Advocacy Update

NIH Funding NewsContact Your Senators by April 23 to Support FY 2014 NIH FundingPlease visit the ASH Advocacy CenterTODAY to send a letter to your Senators as part of a new ASH advocacy campaign to protect the National Institutes of Health (NIH) from ... [Published American Society of Hematology - Apr 19 2013]

Entities: National institutes of Health, Epigenomics AG, Myelodysplastic Syndromes, hematologist

First reported Apr 19 2013 - Updated Apr 19 2013 - 1 reports

Noninvasive Cancer Test Is Effective, Study Finds

A new noninvasive screening test can detect most cases of colorectal cancer and also many precancerous polyps, potentially helping to sharply reduce the death toll from the disease, according to results of a study released on Thursday.Still, the results ... [Published New York Times - Apr 19 2013]

Entities: EXACT Sciences Corp, polyp, colonoscopy, Cancer, Epigenomics AG

First reported Apr 10 2013 - Updated Apr 10 2013 - 1 reports

BioChain licenses Septin9 marker from Epigenomics

BERLINBioChain has licensed Epigenomics methylated Septin9 marker for blood-based detection of colorectal cancer, and as a result, BioChain will now offer a Septin9 assay as a new service through its independent reference laboratory in Beijing. No financial ... [Published Drug Discovery News - Apr 10 2013]

Entities: Epigenomics AG, Colorectal Cancer, Assay

First reported Mar 09 2013 - Updated Mar 09 2013 - 1 reports

BioChain licenses Epigenomicsâ methylated Septin9 marker for blood based detection of colorectal cancer

The German-American cancer molecular diagnostics company Epigenomics AG and leading clinical diagnostics company in cancer and genetic tests, BioChain have announced that BioChain has licensed Epigenomics’ methylated Septin9 marker for the blood based ... [Published PharmaBiz - Mar 09 2013]

Entities: Epigenomics AG, Colorectal Cancer, Assay, Molecular Diagnostics, Cancer

First reported Feb 25 2013 - Updated Feb 25 2013 - 1 reports

US FDA accepts Epigenomics' PMA application for Epi proColon and grants priority review status

The United States Food & Drug Administration (FDA) has accepted Epigenomics' Premarket Approval (PMA) application for Epi proColon. The agency concluded that all information needed for the substantive review is included and has granted priority review ... [Published PharmaBiz - Feb 25 2013]

Entities: Epigenomics AG, FDA Food & Drug Administration, Premarket Approval, Molecular Diagnostics

First reported Feb 22 2013 - Updated Feb 22 2013 - 1 reports

FDA will expedite review of Epigenomics' colon cancer assay

Home » Syndicated Content » Related Biotechnology, Pharmaceutical and Healthcare NewsThe FDA has given priority-review status to Epigenomics' premarket approval application for Epi proColon, a diagnostic test f -More-Original Article: FDA will expedite ... [Published BioPortfolio - Feb 22 2013]

Entities: Epigenomics AG, Colorectal Cancer, Assay

Quotes

...tology/Oncology, professor of medicine and director of the Raymond and Beverly Sackler Center for Biomedical and Physical Sciences at Weill Cornell. "Researchers had thought EZH2 inhibitors would only help patients with a mutation in their EZH2 gene, which represents a small subset of lymphoma patients. What we found is that a majority of lymphomas turn outout to be dependent on normal EZH2, not just mutated EZH2."

Researchers discover master regulator that drives majority of lymphoma [Published EurekAlert! - May 13 2013]

GIS executive director Professor Huck Hui Ng, said that, "Epigenomics is an exciting frontier for biological research and it offers a new perspective to analyse the human genome. We are very pleased to partner with Oxford BioDynamics to employ their EpiSwitch technology for applications in stem cellcell differentiation."

A*STAR, OBD to find epigenetic footprint in stem cells [Published Bio Spectrum Asia - May 13 2013]

Research and Markets (http://www.researchandmarkets.com/research/n3mbc5/epigenetics) has announced the addition of the "Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics,... "

Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interfere ... [Published Financial Services - Apr 23 2013]

...While noting that "biomedical research contributes to improving the health of the American people, as well as the economy" and that "tomorrow's advances in health care depend on today's investments in basic research" the President's proposed budget provides $31 billion for the National Institutes of Health (NIH), a slight increase over the pre-sequestration amount...

April 2013 Advocacy Update [Published American Society of Hematology - Apr 19 2013]

More Content

sort by: Date \| Relevance
Researchers discover master regulator that driv... [Published EurekAlert! - May 13 2013]
A*STAR, OBD to find epigenetic footprint in ste... [Published Bio Spectrum Asia - May 13 2013]
Salk Researchers Chart Epigenomics of Stem Cell... [Published ScienceNewsline - May 10 2013]
Epigenomics AG Announces Q1 2013 Financial Resu... [Published BioSpace - May 08 2013]
PRESS RELEASE: Epigenomics AG: Epigenomics AG A... [Published Tradesignal Online - May 08 2013]
EPIGENOMICS AG : Announces Q1 2013 Financial Re... [Published 4 Traders - May 08 2013]
Molecular Diagnostics in Cancer Testing Report:... [Published Individual.com - Apr 30 2013]
DCI DEEP Mini Symposium [Published Duke University - Apr 28 2013]
Epigenetics Technology Market (Epigenomics, DNA... [Published Financial Services - Apr 23 2013]
EMBO Conference Series: Chromatin and Epigenetics [Published Bionity.com - Apr 23 2013]
April 2013 Advocacy Update [Published American Society of Hematology - Apr 19 2013]
Colonoscopy alternative, but not yet a replacement [Published Bend Bulletin - Apr 19 2013]
Noninvasive test detects colorectal cancer [Published Columbus Dispatch - Apr 19 2013]
Noninvasive Cancer Test Is Effective, Study Finds [Published New York Times - Apr 19 2013]
BioChain licenses Septin9 marker from Epigenomics [Published Drug Discovery News - Apr 10 2013]
Research and Markets: 2013 Analysis of the Glob... [Published Yahoo! Finance - Mar 27 2013]
BioChain licenses Epigenomicsâ methylated Septi... [Published PharmaBiz - Mar 09 2013]
Research and Markets: Competitive Intelligence:... [Published Yahoo! Finance - Mar 01 2013]
US FDA accepts Epigenomics' PMA application for... [Published PharmaBiz - Feb 25 2013]
FDA will expedite review of Epigenomics' colon ... [Published BioPortfolio - Feb 22 2013]
Epigenetics Technology Market (Epigenomics, DNA... [Published PR Newswire: Health - Jan 23 2013]
Research and Markets: Epigenetics Technology Ma... [Published Business Wire Health News - Jan 22 2013]
Global Epigenetics Market Worth $8 Billion by 2017 [Published PR Newswire: Entertainment & Media - Jan 15 2013]
Epigenetics Market is Growing at a CAGR of 25% ... [Published PRWeb - Jan 09 2013]
Epigenomics reports additional data on comparis... [Published PBR - News - Dec 20 2012]
Global Tumor Diagnostics Market Analysis by Ven... [Published PRWeb - Sep 20 2012]
The American Meditation Institute Hosts New Phy... [Published PRWeb - Sep 19 2012]
Mapping a genetic world beyond genes [Published Terra Daily - Sep 12 2012]
HighlyTargeted Epigenomic Treatments May Change... [Published BioPortfolio - Sep 10 2012]
Epigenomics, Present and Future Applications fo... [Published PR Newswire - Sep 10 2012]